Inventiva (IVA) EPS (Basic) (2019 - 2021)

Inventiva (IVA) recorded quarterly EPS (Basic) of -$0.02 in Q1 2021, up 97.88% quarter-over-quarter from -$0.77 in Q4 2020.

Inventiva (IVA) EPS (Basic) (2019 - 2021) Analysis & Trends

Inventiva's EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.02 for Q1 2021.

In Q1 2021, EPS (Basic) changed N/A year-over-year to -$0.02; the TTM figure through Dec 2022 stood at -$0.02 (up 99.14% YoY), while the FY2025 annual figure was -$2.21, up 32.8% from the prior year.
EPS (Basic) was -$0.02 for Q1 2021 at Inventiva, up from -$0.77 in the prior quarter.
In the past five years, EPS (Basic) ranged from a high of -$0.02 in Q1 2021 to a low of -$1.12 in Q4 2019.
Historically, EPS (Basic) has averaged -$0.64 across 3 years, with a median of -$0.77 in 2020.
Biggest YoY gain for EPS (Basic) was 31.48% in 2020; the steepest drop was 31.48% in 2020.
A 3-year view of EPS (Basic) shows it stood at -$1.12 in 2019, then soared by 31.48% to -$0.77 in 2020, then surged by 97.88% to -$0.02 in 2021.
The last three EPS (Basic) figures came in at -$0.02 (Q1 2021), -$0.77 (Q4 2020), and -$1.12 (Q4 2019), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-0.68
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	3.06
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	0.00
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	0.00
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	0.00
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	0.00
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	4.06
9	Abivax	94.37 Bn	94.37 Bn	-	-0.06
10	Inventiva	8.78 Mn	-259.95 Mn	-	-

Download Data